We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NRXS market cap is 16.71M. The company's latest EPS is USD -2.7651 and P/E is -1.12.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 613k | 805k | 646k | 478k | 531k |
Operating Income | -986k | -896k | -1.12M | -3.03M | -1.62M |
Net Income | -14k | -2.17M | -2.24M | -4.9M | -5.31M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1.93M | 2.72M | 2.69M | 2.46M |
Operating Income | -4.12M | -2.97M | -3.37M | -6.66M |
Net Income | -3.73M | -3.03M | -4.78M | -14.63M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 1.48M | 1.58M | 1.54M | 1.24M | 509k |
Total Liabilities | 7.06M | 9.33M | 11.52M | 2.3M | 1.91M |
Total Equity | -5.57M | -7.75M | -9.98M | -1.06M | -1.4M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.79M | 760k | 1.48M | 509k |
Total Liabilities | 1.15M | 1.59M | 7.06M | 1.91M |
Total Equity | 1.64M | -826k | -5.57M | -1.4M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -2.3M | -623k | -1.25M | -4.07M | -6.69M |
Investing | -61k | -8k | -13k | -56k | -72k |
Financing | 2.29M | 422k | 1.06M | 4.63M | 6.59M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -4.14M | -2.23M | -2.3M | -6.69M |
Investing | -28k | -1,000 | -61k | -72k |
Financing | 6.05M | 661k | 2.29M | 6.59M |
Market Cap | 16.71M |
Price to Earnings Ratio | -1.12 |
Price to Sales Ratio | 6.67 |
Price to Cash Ratio | 208.05 |
Price to Book Ratio | -11.69 |
Dividend Yield | - |
Shares Outstanding | 5.29M |
Average Volume (1 week) | 9.09k |
Average Volume (1 Month) | 9.31k |
52 Week Change | -49.84% |
52 Week High | 6.93 |
52 Week Low | 1.80 |
Spread (Intraday) | 3.09 (70.87%) |
Company Name | Neuraxis Inc |
Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
Website | https://www.neuraxis.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions